Interaction involving tadalafil and CYP3A4 inhibition by ritonavir

Author： Loulergue Pierre Gaillard Raphaëël Mir Olivier

ISSN： 0036-5548

Source： Scandinavian Journal of Infectious Diseases, Vol.43, Iss.3, 2011-03, pp. : 239-240

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenomics of Codeine, Morphine, and Morphine-6-Glucuronide: Model-Based Analysis of the Influence of CYP2D6 Activity, UGT2B7 Activity, Renal Impairment, and CYP3A4 Inhibition

By Eissing Thomas Lippert Jörg Willmann Stefan

Molecular Diagnosis & Therapy, Vol. 16, Iss. 1, 2012-02 ,pp. : 43-53

Adis International

Access to resources Recommend Favorite

Impact of CYP3A4 Genotype on Voriconazole Exposure

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 103, Iss. 2, 2018-02 ,pp. : 185-186

John Wiley & Sons Inc

Access to resources Recommend Favorite

Functional Gene Variants of CYP3A4

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 3, 2014-09 ,pp. : 340-348

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Strong CYP3A Inhibition and Induction on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor: Results of Drug‐Drug Interaction Studies in Patients With Advanced Solid Tumors or Lymphoma and a Physiologically Based Pharmacokinetic Analysis

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 58, Iss. 2, 2018-02 ,pp. : 180-192

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 84, Iss. 3, 2018-03 ,pp. : 510-519

John Wiley & Sons Inc

Access to resources Recommend Favorite